Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Newsquawk Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::42589787.png) Newsquawk [@Newsquawk](/creator/twitter/Newsquawk) on x 131.4K followers
Created: 2025-07-21 12:14:42 UTC

🇺🇸US pre-market movers 🇺🇸
ES +0.2% NQ +0.2% RTY +0.7%

$XYZ +9.1%: To replace $HES in the SPX.

$TRI +0.7%: To replace $ANSYS in the NDX.

$VZ +5.0%: EPS & rev. topped exp.; raised FY adj.EPS growth view.

$DPZ +2.8%: US & International SSS beat.

$ROP +1.7%: Profit & rev. beat; raised FY guidance.

$CLF +5.1%: Adj.EBITDA unexpectedly printed positive, with revenue in line.

$SRPT -8.3%: FDA placed a clinical hold on $SRPT's LGMD trials and revoked designation for $SRPT's AAVR74 platform.

$ZK -5.2%: Authorities to crack down on $ZK's practice to inflate sales by insuring vehicles before sale to meet targets.

$EVO -12.9%: Cut revenue guidance.

$KEYS +1.2%: Upgraded at BofA to 'Neutral' from 'Underperform'.

$RCL -0.5%: Downgraded at Truist to 'Hold' from 'Buy'.


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947268999995174916/c:line.svg)

**Related Topics**
[xyz](/topic/xyz)
[$srpt](/topic/$srpt)
[$clf51](/topic/$clf51)
[$rop17](/topic/$rop17)
[sss](/topic/sss)
[$dpz28](/topic/$dpz28)
[rev](/topic/rev)
[$vz50](/topic/$vz50)

[Post Link](https://x.com/Newsquawk/status/1947268999995174916)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Newsquawk Avatar Newsquawk @Newsquawk on x 131.4K followers Created: 2025-07-21 12:14:42 UTC

🇺🇸US pre-market movers 🇺🇸 ES +0.2% NQ +0.2% RTY +0.7%

$XYZ +9.1%: To replace $HES in the SPX.

$TRI +0.7%: To replace $ANSYS in the NDX.

$VZ +5.0%: EPS & rev. topped exp.; raised FY adj.EPS growth view.

$DPZ +2.8%: US & International SSS beat.

$ROP +1.7%: Profit & rev. beat; raised FY guidance.

$CLF +5.1%: Adj.EBITDA unexpectedly printed positive, with revenue in line.

$SRPT -8.3%: FDA placed a clinical hold on $SRPT's LGMD trials and revoked designation for $SRPT's AAVR74 platform.

$ZK -5.2%: Authorities to crack down on $ZK's practice to inflate sales by insuring vehicles before sale to meet targets.

$EVO -12.9%: Cut revenue guidance.

$KEYS +1.2%: Upgraded at BofA to 'Neutral' from 'Underperform'.

$RCL -0.5%: Downgraded at Truist to 'Hold' from 'Buy'.

XXXXX engagements

Engagements Line Chart

Related Topics xyz $srpt $clf51 $rop17 sss $dpz28 rev $vz50

Post Link

post/tweet::1947268999995174916
/post/tweet::1947268999995174916